A Study to Evaluate the Safety of MEDI2338 in Subjects with Chronic Obstructive Pulmonary Disease

Study identifier:CD-RI-MEDI2338-1033

ClinicalTrials.gov identifier:N/A

EudraCT identifier:2010-022879-54

CTIS identifier:N/A

Study Complete

Official Title

A Phase 1, Single Ascending Dose Study to Evaluate the Safety of MEDI2338 in Subjects with Chronic Obstructive Pulmonary Disease

Medical condition

Chronic Obstructive Pulmonary Disease

Phase

Phase 1

Healthy volunteers

No

Study drug

-

Sex

All

Actual Enrollment

31

Study type

Interventional

Age

40 Years - 99 Years

Date

Study Start Date: 01 Mar 2011
Primary Completion Date: 01 Nov 2011
Study Completion Date: 01 Dec 2011

Study design

Allocation: Randomized
Endpoint Classification: Safety Study
Intervention Model: Single Group Assignment
Masking: Single Blind
Primary Purpose: Treatment

Verification:

Verified 01 Oct 2013 by MedImmune, LLC

Sponsors

MedImmune, LLC

Collaborators

-

Inclusion and exclusion criteria